Atlas Trials

Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC

Clinical trial NCT06296563 · RECRUITING

Trial details

NCT number
NCT06296563
Sponsor
Lei ZHAO
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Intrahepatic Cholangiocarcinoma
Start date
2024-03-01
Primary completion
2027-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.